Reset Map4 Results
5501 Fortunes Ridge Drive, Suite O, Durham, North Caroline, 27713 United StatesStem Genomics is a biotech company, located in France and in the USA, specialized in the design of innovative testing technologies for stem cells. A spin-out of the Institute for Regenerative Medicine & Biotherapy (IRMB) and co-founded by Prof. John de Vos and Dr. Said Assou, experts in stem cell genomic integrity, Stem Genomics has emerged from a prestigious scientific environment. Located at the heart of the University Hospital Centre of Montpellier, the IRMB houses research groups working on basic stem cell research and innovative applications for regenerative therapy with the aim of facilitating the transfer from research to clinical applications. Founded in 2018, we work with +150 clients worldwide, from academic institutions to biotech companies and core facilities. We service our North American clients from our laboratory based in the Research Triangle in Durham, North Carolina, and our European and other international clients from our headquarters in Montpellier, France. Stem Genomics is a team of passionate and committed individuals whose aim is to support research scientists in achieving qualitative and reliable cell lines for their work. We have developed in-house expertise in stem cells and in innovative genetic stability assay technologies which enable us to perform most of our tests on our own platform. In parallel, our R&D team is continuously developing latest generation quality controls assays. We pride ourselves on our reactivity and availability in our relationship with our clients throughout the process. Technologies we have selected for stem cell characterization: - Digital PCR (dPCR) is the most accurate PCR method for assessing the genetic integrity of stem cells through the detection of Copy Number Variants (CNVs). It is ideal for regular in-process controls and fast clone screening. - G-banding karyotyping is helpful in providing an exhaustive structural and numerical variant analysis. - Next-Generation Sequencing (NGS) offers a hypothesis-free approach that does not require prior knowledge of sequence information. NGS enables the simultaneous analysis of numerous genes, making it both feasible and cost effective. It is particularly well-suited to key stages in the workflow such as cell line acquisition, banking and/or end of workflow.
400 Park Offices Drive Room 104, Research Triangle Park Durham, NC, 27703 United StatesStem Genomics is a biotech company, located in France and in the USA, specialized in the design of innovative testing technologies for stem cells. A spin-out of the Institute for Regenerative Medicine & Biotherapy (IRMB) and co-founded by Prof. John de Vos and Dr. Said Assou, experts in stem cell genomic integrity, Stem Genomics has emerged from a prestigious scientific environment. Located at the heart of the University Hospital Centre of Montpellier, the IRMB houses research groups working on basic stem cell research and innovative applications for regenerative therapy with the aim of facilitating the transfer from research to clinical applications. Founded in 2018, we work with +150 clients worldwide, from academic institutions to biotech companies and core facilities. We service our North American clients from our laboratory based in the Research Triangle in Durham, North Carolina, and our European and other international clients from our headquarters in Montpellier, France. Stem Genomics is a team of passionate and committed individuals whose aim is to support research scientists in achieving qualitative and reliable cell lines for their work. We have developed in-house expertise in stem cells and in innovative genetic stability assay technologies which enable us to perform most of our tests on our own platform. In parallel, our R&D team is continuously developing latest generation quality controls assays. We pride ourselves on our reactivity and availability in our relationship with our clients throughout the process. Technologies we have selected for stem cell characterization: - Digital PCR (dPCR) is the most accurate PCR method for assessing the genetic integrity of stem cells through the detection of Copy Number Variants (CNVs). It is ideal for regular in-process controls and fast clone screening. - G-banding karyotyping is helpful in providing an exhaustive structural and numerical variant analysis. - Next-Generation Sequencing (NGS) offers a hypothesis-free approach that does not require prior knowledge of sequence information. NGS enables the simultaneous analysis of numerous genes, making it both feasible and cost effective. It is particularly well-suited to key stages in the workflow such as cell line acquisition, banking and/or end of workflow.
IRMB - Hopital Saint Eloi 80 avenue Augustin Fliche Montpellier Cedex 5, Hérault, 34295 FranceStem Genomics is a biotech company, located in France and in the USA, specialized in the design of innovative testing technologies for stem cells. A spin-out of the Institute for Regenerative Medicine & Biotherapy (IRMB) and co-founded by Prof. John de Vos and Dr. Said Assou, experts in stem cell genomic integrity, Stem Genomics has emerged from a prestigious scientific environment. Located at the heart of the University Hospital Centre of Montpellier, the IRMB houses research groups working on basic stem cell research and innovative applications for regenerative therapy with the aim of facilitating the transfer from research to clinical applications. Founded in 2018, we work with +150 clients worldwide, from academic institutions to biotech companies and core facilities. We service our North American clients from our laboratory based in the Research Triangle in Durham, North Carolina, and our European and other international clients from our headquarters in Montpellier, France. Stem Genomics is a team of passionate and committed individuals whose aim is to support research scientists in achieving qualitative and reliable cell lines for their work. We have developed in-house expertise in stem cells and in innovative genetic stability assay technologies which enable us to perform most of our tests on our own platform. In parallel, our R&D team is continuously developing latest generation quality controls assays. We pride ourselves on our reactivity and availability in our relationship with our clients throughout the process. Technologies we have selected for stem cell characterization: - Digital PCR (dPCR) is the most accurate PCR method for assessing the genetic integrity of stem cells through the detection of Copy Number Variants (CNVs). It is ideal for regular in-process controls and fast clone screening. - G-banding karyotyping is helpful in providing an exhaustive structural and numerical variant analysis. - Next-Generation Sequencing (NGS) offers a hypothesis-free approach that does not require prior knowledge of sequence information. NGS enables the simultaneous analysis of numerous genes, making it both feasible and cost effective. It is particularly well-suited to key stages in the workflow such as cell line acquisition, banking and/or end of workflow.
Cap Sigma 1682 rue de la Valsière Grabels, 34790 FranceStem Genomics is a biotech company, located in France and in the USA, specialized in the design of innovative testing technologies for stem cells. A spin-out of the Institute for Regenerative Medicine & Biotherapy (IRMB) and co-founded by Prof. John de Vos and Dr. Said Assou, experts in stem cell genomic integrity, Stem Genomics has emerged from a prestigious scientific environment. Located at the heart of the University Hospital Centre of Montpellier, the IRMB houses research groups working on basic stem cell research and innovative applications for regenerative therapy with the aim of facilitating the transfer from research to clinical applications. Founded in 2018, we work with +150 clients worldwide, from academic institutions to biotech companies and core facilities. We service our North American clients from our laboratory based in the Research Triangle in Durham, North Carolina, and our European and other international clients from our headquarters in Montpellier, France. Stem Genomics is a team of passionate and committed individuals whose aim is to support research scientists in achieving qualitative and reliable cell lines for their work. We have developed in-house expertise in stem cells and in innovative genetic stability assay technologies which enable us to perform most of our tests on our own platform. In parallel, our R&D team is continuously developing latest generation quality controls assays. We pride ourselves on our reactivity and availability in our relationship with our clients throughout the process. Technologies we have selected for stem cell characterization: - Digital PCR (dPCR) is the most accurate PCR method for assessing the genetic integrity of stem cells through the detection of Copy Number Variants (CNVs). It is ideal for regular in-process controls and fast clone screening. - G-banding karyotyping is helpful in providing an exhaustive structural and numerical variant analysis. - Next-Generation Sequencing (NGS) offers a hypothesis-free approach that does not require prior knowledge of sequence information. NGS enables the simultaneous analysis of numerous genes, making it both feasible and cost effective. It is particularly well-suited to key stages in the workflow such as cell line acquisition, banking and/or end of workflow.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.